Study: NCT01066923

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daily aspirin (ASA)
Description: Two weeks 82 mg aspirin taken orally prior to exercise protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daily aspirin (ASA)
Description: Two weeks 82 mg aspirin taken orally prior to exercise protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daily aspirin (ASA)
Description: Two weeks 82 mg aspirin taken orally prior to exercise protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daily aspirin (ASA)
Description: Two weeks 82 mg aspirin taken orally prior to exercise protocol

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active cooling
Description: Active cooling to remediate heat stress following exercise by placing hands and forearms into cold water

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active cooling
Description: Active cooling to remediate heat stress following exercise by placing hands and forearms into cold water

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active cooling
Description: Active cooling to remediate heat stress following exercise by placing hands and forearms into cold water

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active cooling
Description: Active cooling to remediate heat stress following exercise by placing hands and forearms into cold water

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acute aspirin (ASA)
Description: 325 mg chewable aspirin administered immediately following exercise

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acute aspirin (ASA)
Description: 325 mg chewable aspirin administered immediately following exercise

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acute aspirin (ASA)
Description: 325 mg chewable aspirin administered immediately following exercise

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acute aspirin (ASA)
Description: 325 mg chewable aspirin administered immediately following exercise

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Passive cooling
Description: Removing protective garments for passive cooling following exercise

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Passive cooling
Description: Removing protective garments for passive cooling following exercise

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Passive cooling
Description: Removing protective garments for passive cooling following exercise

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Passive cooling
Description: Removing protective garments for passive cooling following exercise

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daily placebo
Description: Placebo comparator for daily aspirin therapy

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Daily placebo
Description: Placebo comparator for daily aspirin therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daily placebo
Description: Placebo comparator for daily aspirin therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daily placebo
Description: Placebo comparator for daily aspirin therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acute placebo
Description: Placebo comparator for acute aspirin therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acute placebo
Description: Placebo comparator for acute aspirin therapy

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Acute placebo
Description: Placebo comparator for acute aspirin therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acute placebo
Description: Placebo comparator for acute aspirin therapy